Treatment Choice and Cardiovascular Risk in Chronic Spontaneous Urticaria
Study limitation reported by the research below: “Reciprocal exclusion of oCS after index may have selected a more stable, less severe omalizumab-treated population, inflating the apparent cardiovascular benefit of omalizumab.”